Gladice Wallraven

3PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 14, 2026
Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian Cancer.

Robert L Coleman, Rodney Rocconi, Bradley J Monk

|Feb 13, 2023
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.

Peter Anderson, Maurizio Ghisoli, Brian D Crompton

|Oct 26, 2021
Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.

Vedin Barve, Ned Adams, Laura Stanbery

Pageof 1

Frequent Collaborators

2 joint publications

John Nemunaitis

2 joint publications

Ernest Bognar

1 joint publications

Vedin Barve

1 joint publications

Peter Anderson